2022
PharmacoEconomics, (2022).41 5 10.1007/s40273-022-01223-w.
2022
medRxiv (2022). 10.1101/2022.12.14.22283422.
2022
The Lancet Global health, (2022).11 1 10.1016/S2214-109X(22)00475-2.
2022
mSystems, (2022).8 1 10.1128/msystems.00974-22.
2022
Nature communications, (2022).13 1 10.1038/s41467-022-34240-6.
Evaluating the use of social contact data to produce age-specific forecasts of SARS-CoV-2 incidence.
2022
medRxiv (2022). 10.1101/2022.12.02.22282935.
2022
PLoS computational biology, (2022).18 11 10.1371/journal.pcbi.1010746.
Challenges of using modelling evidence in the visceral leishmaniasis elimination programme in India.
2022
PLOS global public health, (2022).2 11 10.1371/journal.pgph.0001049.
2022
medRxiv (2022). 10.1101/2022.11.23.22282690.
epiforecasts/covid.german.forecasts.
2022
, Github (2022).
